Cannabis shares pull back in Q2 as U.S. regulatory momentum fizzles

The Botanicals Podcast

Jul 21 2021 | 00:20:20

00:00 / 00:20:20

Show Notes

Nasdaq IR Intelligence analyst Saleem Daya explains why the sector's heated year-end performance has cooled; cites rising yields, retail investor fatigue as action on U.S federal legislation remains stalled.

Other Episodes

Episode 0

January 12, 2021 • 00:20:25

Cannabis Shares Pick Up Pace As 2021 Regulatory Momentum Eyed

Saleem Daya, an analyst with Nasdaq IR Intelligence in Toronto, sees U.S. cannabis regulation poised for a rehaul in 2021 given Democrats' U.S. Senate...

Episode 18

December 17, 2021 • 00:13:40

Cannabis Shares Underperform Going Into Year-End Amid U.S. Regulatory Logjam

Although adult-use sales of cannabis remain robust in U.S. states where it is legal, Nasdaq IR Intelligence analyst Saleem Daya sees continued stock underperformance...

Episode 0

September 29, 2020 • 00:18:13

Cannabis sector outperforms S&P 500 as U.S. sales grow

Saleem Daya, analyst at Nasdaq corporate solutions in Toronto, updates John Lothian News on the Q2 performance of listed cannabis shares amid strong U.S....